Healthcare provider profile · identity verified

Brian A Johnson, MD

Allopathic & Osteopathic Physicians|Family Medicine · WICHITA, KS · NPI 1306803911

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Brian A Johnson, MD received $37.96 in general payments during 2025 across 2 reported records.

SANOFI PASTEUR INC. accounted for 59.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$37.96

2 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
SANOFI PASTEUR INC.	Unresolved — no canonical attribution shown	$22.41	59.0%	1	2025
Exact Sciences Corporation	Unresolved — no canonical attribution shown	$15.55	41.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$37.96	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
BEYFORTUS Normalized: beyfortus	Biological	SANOFI PASTEUR INC.	$22.41	1	2025
Source payment records 2025-10-02 · SANOFI PASTEUR INC. · $22.41 · Open Payments source
FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE Normalized: flublok quadrivalent northern hemisphere	Biological	SANOFI PASTEUR INC.	$22.41	1	2025
Source payment records 2025-10-02 · SANOFI PASTEUR INC. · $22.41 · Open Payments source
The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit	Device	Exact Sciences Corporation	$15.55	1	2025
Source payment records 2025-04-23 · Exact Sciences Corporation · $15.55 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	621	149
Atorvastatin Calcium	Atorvastatin Calcium	578	154
Gabapentin	Gabapentin	532	102
Pantoprazole Sodium	Pantoprazole Sodium	457	114
Levothyroxine Sodium	Levothyroxine Sodium	406	95
Omeprazole	Omeprazole	320	70
Metoprolol Succinate	Metoprolol Succinate	311	75
Sertraline Hcl	Sertraline Hcl	305	60
Prednisone	Prednisone	292	176
Losartan Potassium	Losartan Potassium	286	75
Furosemide	Furosemide	264	71
Tamsulosin Hcl	Tamsulosin Hcl	256	71
Meloxicam	Meloxicam	239	57
Simvastatin	Simvastatin	238	58
Lisinopril	Lisinopril	237	65
Potassium Chloride	Potassium Chloride	211	49
Trazodone Hcl	Trazodone Hcl	207	48
Tramadol Hcl	Tramadol Hcl	197	49
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	192	48
Cephalexin	Cephalexin	185	92
Duloxetine Hcl	Duloxetine Hcl	177	31
Allopurinol	Allopurinol	171	36
Lorazepam	Lorazepam	166	32
Metformin Hcl	Metformin Hcl	157	38
Metformin Hcl Er	Metformin Hcl	156	35
Citalopram Hbr	Citalopram Hydrobromide	152	29
Mirtazapine	Mirtazapine	150	27
Metoprolol Tartrate	Metoprolol Tartrate	139	29
Azithromycin	Azithromycin	131	103
Fluoxetine Hcl	Fluoxetine Hcl	127	25
Zolpidem Tartrate	Zolpidem Tartrate	124	27
Doxycycline Hyclate	Doxycycline Hyclate	121	84
Tizanidine Hcl	Tizanidine Hcl	117	30
Glimepiride	Glimepiride	115	28
Eliquis	Apixaban	114	21
Carvedilol	Carvedilol	110	28
Ezetimibe	Ezetimibe	108	24
Synthroid	Levothyroxine Sodium	101	14
Clonazepam	Clonazepam	100	19
Alprazolam	Alprazolam	98	25
Escitalopram Oxalate	Escitalopram Oxalate	96	20
Venlafaxine Hcl Er	Venlafaxine Hcl	94	16
Alendronate Sodium	Alendronate Sodium	93	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	89	25
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	87	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	85	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	85	21
Rosuvastatin Calcium	Rosuvastatin Calcium	83	26
Oxycodone Hcl	Oxycodone Hcl	81	24
Albuterol Sulfate Hfa	Albuterol Sulfate	80	35
Jardiance	Empagliflozin	79	13
Farxiga	Dapagliflozin Propanediol	77	16
Hydrochlorothiazide	Hydrochlorothiazide	76	25
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	74	59
Chlorthalidone	Chlorthalidone	74	16
Famotidine	Famotidine	72	17
Pravastatin Sodium	Pravastatin Sodium	72	18
Spironolactone	Spironolactone	70	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	69	20
Warfarin Sodium	Warfarin Sodium	69	11
Ondansetron Odt	Ondansetron	68	21
Fenofibrate	Fenofibrate	64	15
Finasteride	Finasteride	64	12
Fluticasone Propionate	Fluticasone Propionate	64	21
Clopidogrel	Clopidogrel Bisulfate	61	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	61	17
Ozempic	Semaglutide	61	suppressed
Bumetanide	Bumetanide	60	15
Quetiapine Fumarate	Quetiapine Fumarate	60	11
Ropinirole Hcl	Ropinirole Hcl	60	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	60	11
Baclofen	Baclofen	59	suppressed
Estradiol	Estradiol	58	17
Atenolol	Atenolol	57	14
Celecoxib	Celecoxib	57	11
Montelukast Sodium	Montelukast Sodium	57	suppressed
Buspirone Hcl	Buspirone Hcl	55	suppressed
Xarelto	Rivaroxaban	55	suppressed
Memantine Hcl	Memantine Hcl	51	suppressed
Valsartan	Valsartan	51	11
Naproxen	Naproxen	48	14
Amitriptyline Hcl	Amitriptyline Hcl	45	suppressed
Diclofenac Sodium	Diclofenac Sodium	45	suppressed
Januvia	Sitagliptin Phosphate	44	suppressed
Bupropion Xl	Bupropion Hcl	41	suppressed
Raloxifene Hcl	Raloxifene Hcl	41	suppressed
Amiodarone Hcl	Amiodarone Hcl	40	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	39	11
Klor-Con M20	Potassium Chloride	39	12
Tresiba Flextouch U-100	Insulin Degludec	37	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	36	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	36	11
Nortriptyline Hcl	Nortriptyline Hcl	34	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	34	27
Vitamin D2	Ergocalciferol (Vitamin D2)	34	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	33	suppressed
Temazepam	Temazepam	33	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	32	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	19
Pregabalin	Pregabalin	32	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Acyclovir	Acyclovir	29	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	24
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	29	20
Levetiracetam	Levetiracetam	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Fluconazole	Fluconazole	28	18
Methylprednisolone	Methylprednisolone	28	27
Ramipril	Ramipril	28	suppressed
Ventolin Hfa	Albuterol Sulfate	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Solifenacin Succinate	Solifenacin Succinate	24	suppressed
Amoxicillin	Amoxicillin	23	22
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	23	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	23	suppressed
Tradjenta	Linagliptin	22	suppressed
Verapamil Er	Verapamil Hcl	22	suppressed
Anastrozole	Anastrozole	21	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Hydrocortisone	Hydrocortisone	21	suppressed
Terbinafine Hcl	Terbinafine Hcl	21	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	19	suppressed
Cefdinir	Cefdinir	19	14
Creon	Lipase/Protease/Amylase	19	suppressed
Diazepam	Diazepam	19	suppressed
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Mounjaro	Tirzepatide	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Glipizide	Glipizide	17	suppressed
Rizatriptan	Rizatriptan Benzoate	17	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Tresiba Flextouch U-200	Insulin Degludec	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Risperidone	Risperidone	15	suppressed
Tenivac	Tetanus-Diphtheria Toxoids/Pf	15	15
Levemir Flexpen	Insulin Detemir	14	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	11
Azelastine Hcl	Azelastine Hcl	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Etodolac Er	Etodolac	12	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$37.96 · 2 records	SANOFI PASTEUR INC.	BEYFORTUS, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, The Cologuard Plus Collection Kit	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error